Upload Avatar (500 x 500)
Sheng Wang
wangsheng@sibcb.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Life Sciences
  • 2007-09 to 2013-09 PhD: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
  • 2005-03 to 2007-07 Dual Bachelor's Degree: Wuhan University
  • 2003-09 to 2007-06 Bachelor's Degree: Huazhong Agricultural University
  • 2020-04 to Present - Chinese Academy of Sciences Center for Excellence in Molecular Cell Science - Researcher
  • 2018-09 to 2020-03 - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences - Researcher
  • 2013-12 to 2018-06 - University of North Carolina at Chapel Hill (USA) - Postdoctoral Researcher
  • Tan Jiazhen Life Science Award (2023): Other
  • Top 100 in the First Shanghai High-Value Patent Operation Competition (2022): Provincial
  • Top 10 Emerging Scientists in China (2022): National
  • National Outstanding Youth Award (2022): National
  • WuXi AppTec Life Chemistry Research Award (2022): National
  • Outstanding Young Scientist of the 8th Chinese Academy of Sciences Shanghai Branch (2022): Institutional
  • Excellent Mentor of the Chinese Academy of Sciences (2022): Institutional
  • Shanghai Youth Science and Technology Star (2020): Provincial
Neuropsychiatric Drug Pharmacology
Drug Design
Material Basis of Hallucinations
  • Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders, Neuron, 2024
  • Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants, Chemical Reviews, 2024
  • Flexible scaffold-based cheminformatics approach for polypharmacological drug design, Cell, 2024
  • Structural insights into constitutive activity of 5-HT6 receptor, Proceedings of the National Academy of Sciences of the United States of America, 2023
  • Structural insights into sphingosine-1-phosphate receptor activation, Proceedings of the National Academy of Sciences of the United States of America, 2022
  • The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands, Nature Communications, 2022
  • Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties, Nature Neuroscience, 2022
  • Structure-based discovery of nonhallucinogenic psychedelic analogs, Science, 2022
  • 2-Phenylcyclopropylmethylamine Derivatives as Dopamine D-2 Receptor Partial Agonists: Design, Synthesis, and Biological Evaluation, Journal of Medicinal Chemistry, 2021
  • Haloperidol bound D 2 dopamine receptor structure inspired the discovery of subtype selective ligands, Nature Communications, 2020
  • Ultra-large library docking for discovering new chemotypes, Nature, 2019
  • Structural determinants of 5-HT2B receptor activation and biased agonism, Nature Structural & Molecular Biology, 2018
  • Structure of a nanobody-stabilized active state of the kappa opioid receptor, Cell, 2018
  • Structure of the D 2 dopamine receptor bound to the atypical antipsychotic drug risperidone, Nature, 2018
  • D 4 Dopamine Receptor High Resolution Structures Enable the Discovery of Selective Agonists, Science, 2017
  • Crystal Structure of an LSD-Bound Human Serotonin Receptor, Cell, 2017
  • Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65, Nature, 2015
  • New insights into the regulation of Axin function in canonical Wnt signaling pathway, Protein & Cell, 2014
  • Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function, Cell Reports, 2014
  • Nature Chem Biol, Nature Chem Biol, 2013
  • Proc Natl Acad Sci USA, Proc Natl Acad Sci USA, 2011
  • A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/beta-catenin signaling and colon cancer cell tumorigenesis, Cell Research, 2011
Neuropsychiatric Drug Pharmacology Design Hallucinations Material Basis Research Innovation Therapeutics

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.